Related Experiment Video
Updated: Jun 6, 2026
Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017
Microglia Attenuate Neuroinflammation After Subarachnoid Hemorrhage by Modulating Astrocyte Phenotypic Transformation
Yuxiao Meng1, Yuanzhe Dong1, Jiang Shao2
1Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Abstract:
Neuroinflammation mediated by microglia-astrocyte interactions significantly contributes to secondary brain injury after subarachnoid hemorrhage (SAH). Retinoic acid receptor alpha (RARα) has emerged as a potential modulator of neuroinflammation. However, its specific mechanisms in the interaction between microglia and astrocytes after SAH are not yet known. This study investigated whether RARα activation might alleviate neuroinflammation post-SAH by regulating microglial-astrocytic crosstalk via the Mafb/Msr1/PI3K-Akt signaling axis. An in vivo SAH model in male Sprague-Dawley rats was established through endovascular perforation. In vitro, a microglia-astrocyte co-culture system was subjected to oxyhemoglobin treatment to mimic SAH conditions. The RARα-specific agonist Am80 was administered to activate RARα signaling. Key molecular markers (Mafb, Msr1, and PI3K/Akt), pro-/anti-inflammatory cytokines, and glial activation phenotypes were evaluated via western blotting and immunofluorescence. Functional recovery was assessed with neurobehavioral tests. Pathway-specific inhibitors were used for mechanistic validation. RARα activation markedly attenuated neuroinflammation, enhanced neurological outcomes in SAH rats, significantly decreased levels of pro-inflammatory factors, and inhibited neuroinflammation mediated by microglia. Mechanistically, Am80 was found to upregulate the transcription factor Mafb and its downstream target Msr1, thereby triggering PI3K/Akt phosphorylation. This cascade inhibited NF-κB-mediated pro-inflammatory cytokine release and enhanced anti-inflammatory factors. Critically, blockade of PI3K/Akt or knockdown of Mafb/Msr1 abolished the anti-inflammatory effects of Am80. In addition, the inflammatory factor receptors TNF-αR and IL6R were demonstrated to be important mediators of microglia and astrocyte interaction. RARα activation mitigates SAH-induced neuroinflammation by modulating microglial-astrocyte interactions through the Mafb/Msr1/PI3K-Akt pathway. Our findings identified RARα as a promising therapeutic target for ameliorating neuroinflammation and improving recovery after SAH.
Insights
Retinoic acid receptor alpha (RARα) activation reduces brain inflammation after subarachnoid hemorrhage (SAH) by controlling microglia-astrocyte communication. This approach improves neurological function and offers a new therapeutic target for SAH recovery.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Microglia-astrocyte interactions drive neuroinflammation and secondary brain injury post-subarachnoid hemorrhage (SAH).
- Retinoic acid receptor alpha (RARα) shows potential in modulating neuroinflammation, but its role in SAH-related microglial-astrocytic crosstalk is unclear.
Purpose of the Study:
- To investigate if RARα activation alleviates neuroinflammation after SAH by regulating microglial-astrocytic crosstalk via the Mafb/Msr1/PI3K-Akt signaling axis.
- To explore RARα as a potential therapeutic target for improving outcomes after SAH.
Main Methods:
- Established an in vivo SAH rat model and an in vitro microglia-astrocyte co-culture system treated with oxyhemoglobin.
- Administered the RARα agonist Am80 and pathway-specific inhibitors.
- Evaluated molecular markers (Mafb, Msr1, PI3K/Akt), cytokines, glial activation, and neurobehavioral outcomes.
Main Results:
- RARα activation with Am80 significantly attenuated neuroinflammation and improved neurological function in SAH rats.
- Am80 upregulated Mafb and Msr1, activating the PI3K/Akt pathway, which inhibited NF-κB-mediated inflammation and boosted anti-inflammatory factors.
- Blocking PI3K/Akt or reducing Mafb/Msr1 abolished Am80's anti-inflammatory effects, confirming the pathway's importance.
Conclusions:
- RARα activation mitigates SAH-induced neuroinflammation by modulating microglial-astrocyte interactions through the Mafb/Msr1/PI3K-Akt pathway.
- RARα represents a promising therapeutic target for ameliorating neuroinflammation and enhancing recovery following SAH.
